研究文章
淋巴细胞亚群分析和细胞因子在COVID-19-Associated肺炎和社区获得性肺炎
|
| 变量 |
或 |
95%可信区间 |
|
|
| CD3+CD4+% lym |
0.951 |
0.637 - -1.422 |
0.808 |
| CD19+% lym |
1.048 |
0.805 - -1.363 |
0.729 |
| CD3+% lymcnt |
0.871 |
0.54 - -1.402 |
0.569 |
| CD16+CD56+% lym |
1.338 |
1.032 - -1.736 |
0.028 |
| CD3+CD8+% lym |
1.334 |
0.886 - -2.009 |
0.167 |
| 4/8的比例 |
1.538 |
1.166 - -2.028 |
0.002 |
| CD19+ |
0.743 |
0.566 - -0.975 |
0.032 |
| CD3+CD4+ |
1.822 |
1.417 - -2.343 |
< 0.001 |
| CD16+CD56+ |
1.102 |
0.838 - -1.449 |
0.488 |
| CD3+ |
1.174 |
0.776 - -1.778 |
0.447 |
| CD3+CD8+ |
0.834 |
0.636 - -1.094 |
0.19 |
|
|
